Northwest Biotherapeutics, Inc. (NWBO)

USD 0.27

(1.89%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 27.94 Million 31.32 Million 40.16 Million 32.89 Million 9.12 Million 24.66 Million
Total Current Assets 4.12 Million 9.42 Million 17.29 Million 15.51 Million 3.2 Million 23.79 Million
Cash And Short Term Investments 2.12 Million 6.96 Million 15.16 Million 9.98 Million 372 Thousand 22.22 Million
Cash and Cash Equivalents 2.12 Million 6.96 Million 15.16 Million 9.98 Million 372 Thousand 22.22 Million
Short Term Investments - - - - - -
Net Receivables - - - - - -
Inventory - - - - - -
Other Current Assets 1.99 Million 2.46 Million 2.12 Million 5.52 Million 2.82 Million 1.57 Million
Total Non-Current Assets 23.81 Million 21.89 Million 22.87 Million 17.38 Million 5.92 Million 869 Thousand
Net PPE 21.46 Million 19.63 Million 19.91 Million 14.6 Million 5.13 Million 108 Thousand
Good Will And Intangible Assets 1.91 Million 1.91 Million 1.91 Million 1.91 Million - -
Good Will 626 Thousand 626 Thousand 626 Thousand 626 Thousand - -
Intangible Assets 1.29 Million 1.29 Million 1.29 Million 1.29 Million - -
Long-Term Investments 79 Thousand 79 Thousand 79 Thousand 79 Thousand 10 Thousand 10 Thousand
Tax Assets - -79 Thousand -79 Thousand -79 Thousand - -
Other Non Current Assets 361 Thousand 345 Thousand 1.03 Million 867 Thousand 788 Thousand 751 Thousand
Other Assets - - - - - -
Total Liabilities 74.92 Million 159.42 Million 164.15 Million 395.84 Million 52.69 Million 71.82 Million
Total Current Liabilities 45.2 Million 126 Million 133.76 Million 382.42 Million 41.19 Million 69.84 Million
Account Payables 13.78 Million 17.64 Million 10.94 Million 12.74 Million 7.19 Million 20.09 Million
Tax Payables - - - - - -
Short Term Debt 20.79 Million 15.89 Million 7.55 Million 6.43 Million 6.53 Million 14.81 Million
Deferred Revenue - - 250 Thousand - - 4.8 Million
Other Current Liabilities 10.62 Million 92.47 Million 115.01 Million 363.24 Million 27.47 Million 30.13 Million
Total Non Current Liabilities 29.71 Million 33.42 Million 30.38 Million 13.42 Million 11.5 Million 1.98 Million
Long-Term Debt 20.31 Million 10.36 Million 30.38 Million 13.42 Million 11.5 Million 1.98 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 9.4 Million 23.06 Million - - - -
Other Liabilities - - - - - -
Total Equity -46.97 Million -128.1 Million -123.99 Million -362.94 Million -43.56 Million -47.15 Million
Stock Holders Equity -46.97 Million -128.1 Million -123.99 Million -362.94 Million -43.56 Million -47.15 Million
Common Stock 1.17 Million 1.06 Million 948 Thousand 830 Thousand 614 Thousand 523 Thousand
Retained Earnings -1.35 Billion -1.29 Billion -1.19 Billion -1.37 Billion -839.9 Million -824.41 Million
Accumulated other comprehensive income 1.53 Million 3.14 Million 357 Thousand -1.14 Million 836 Thousand 1 Million
Common Stock Equity -46.97 Million -128.1 Million -123.99 Million -362.94 Million -43.56 Million -47.15 Million
Capital Lease Obligation 4.45 Million 4.72 Million 5.54 Million 5.08 Million 5.3 Million -
Total Investments 79 Thousand 79 Thousand 79 Thousand 79 Thousand 10 Thousand 10 Thousand
Total Debt 45.56 Million 26.25 Million 37.93 Million 19.85 Million 18.03 Million 16.79 Million
Net Debt 43.43 Million 19.28 Million 22.76 Million 9.87 Million 17.66 Million -5.42 Million

Balance Sheet Charts